Viva, Biotech

Viva Biotech Announces Its 2025 Interim Results: CRO Revenue Returned to Positive Growth, New CDMO Commercialization Projects Showed Promising Growth

28.08.2025 - 14:25:41

Viva Biotech China Hong Kong

View original content:https://www.prnewswire.co.uk/news-releases/viva-biotech-announces-its-2025-interim-results-cro-revenue-returned-to-positive-growth-new-cdmo-commercialization-projects-showed-promising-growth-302541043.html

@ prnewswire.co.uk | CH0038389992 VIVA
Lerne live von den Börsen-Profis – melde dich jetzt kostenlos an.